Published in Am J Geriatr Psychiatry on February 01, 2010
Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology (2014) 2.26
Late-life depression, mild cognitive impairment, and dementia. JAMA Neurol (2013) 1.52
Satisfaction With a Family-Focused Intervention for Mild Cognitive Impairment Dyads. J Nurs Scholarsh (2016) 1.47
Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study. J Clin Psychiatry (2013) 1.41
Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment-Part 1. Alzheimers Dement (2011) 1.19
Late-life depression as a risk factor for mild cognitive impairment or Alzheimer's disease in 30 US Alzheimer's disease centers. J Alzheimers Dis (2012) 1.14
Sex differences in cognitive impairment and Alzheimer's disease. Front Neuroendocrinol (2014) 1.08
The complex relationship between depression and dementia. Ann Indian Acad Neurol (2010) 1.03
Dementia and cognitive impairment: epidemiology, diagnosis, and treatment. Clin Geriatr Med (2014) 1.03
Medial temporal lobe atrophy in Alzheimer's disease/mild cognitive impairment with depression. Br J Radiol (2014) 0.97
Mild cognitive impairment and depressive symptoms in elderly patients with diabetes: prevalence, risk factors, and comorbidity. J Diabetes Res (2014) 0.94
Protein binding in patients with late-life depression. Arch Gen Psychiatry (2011) 0.94
Mild worry symptoms predict decline in learning and memory in healthy older adults: a 2-year prospective cohort study. Am J Geriatr Psychiatry (2012) 0.91
Depressive symptoms precede memory decline, but not vice versa, in non-demented older adults. J Am Geriatr Soc (2014) 0.91
Brainstem: neglected locus in neurodegenerative diseases. Front Neurol (2011) 0.90
The effects of meditation on perceived stress and related indices of psychological status and sympathetic activation in persons with Alzheimer's disease and their caregivers: a pilot study. Evid Based Complement Alternat Med (2012) 0.90
Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: the population-based aging in the Chianti Area (InCHIANTI) Study. J Alzheimers Dis (2011) 0.89
Cognitive decline in patients with dementia as a function of depression. Am J Geriatr Psychiatry (2011) 0.89
Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments. Curr Psychiatry Rep (2014) 0.89
Psychiatry: life events and social support in late life depression. Clinics (Sao Paulo) (2011) 0.89
Cognitive rehabilitation therapies for Alzheimer's disease: a review of methods to improve treatment engagement and self-efficacy. Neuropsychol Rev (2013) 0.89
Baseline disability in activities of daily living predicts dementia risk even after controlling for baseline global cognitive ability and depressive symptoms. Int J Geriatr Psychiatry (2012) 0.88
Longitudinal Association of Dementia and Depression. Am J Geriatr Psychiatry (2014) 0.88
Diffusion tensor imaging in Alzheimer's disease and affective disorders. Eur Arch Psychiatry Clin Neurosci (2014) 0.87
Mild cognitive impairment, poor episodic memory, and late-life depression are associated with cerebral cortical thinning and increased white matter hyperintensities. Front Aging Neurosci (2014) 0.87
Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment? Am J Geriatr Psychiatry (2013) 0.85
Modifiable risk factors for Alzheimer disease and subjective memory impairment across age groups. PLoS One (2014) 0.85
Depression associated with dementia. Z Gerontol Geriatr (2015) 0.85
Psychosocial Risk Factors for Cognitive Decline in Late-Life Depression: Findings from the MTLD-III Study. Can Geriatr J (2015) 0.85
Central CRF system perturbation in an Alzheimer's disease knockin mouse model. Neurobiol Aging (2012) 0.85
Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability. J Int Neuropsychol Soc (2012) 0.85
Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment. PLoS One (2015) 0.85
Depression and incident Alzheimer disease: the impact of disease severity. Am J Geriatr Psychiatry (2013) 0.83
Heterogenous mechanisms of mild cognitive impairment in Parkinson's disease. J Neural Transm (Vienna) (2011) 0.83
Under-treatment of depression in older persons. J Affect Disord (2011) 0.83
Cognitive deficits in geriatric depression: clinical correlates and implications for current and future treatment. Psychiatr Clin North Am (2013) 0.83
Cognitive impairment, depression, comorbidity of the two and associated factors among the early sixties in a rural Korean community. PLoS One (2013) 0.83
Trajectories of Depressive Symptoms in Older Adults and Risk of Dementia. JAMA Psychiatry (2016) 0.83
Feasibility and Effect Sizes of the Revised Daily Engagement of Meaningful Activities Intervention for Individuals With Mild Cognitive Impairment and Their Caregivers. J Gerontol Nurs (2016) 0.81
Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene. Int J Alzheimers Dis (2011) 0.81
Cognitive impairment with and without depression history: an analysis of white matter microstructure. J Psychiatry Neurosci (2014) 0.80
Depression and incident dementia. An 8-year population-based prospective study. PLoS One (2013) 0.80
DNA methylation and single nucleotide variants in the brain-derived neurotrophic factor (BDNF) and oxytocin receptor (OXTR) genes are associated with anxiety/depression in older women. Front Genet (2015) 0.79
[Depression in old age, part 1 : Origin, clinical symptoms, diagnosis and interaction between depression and dementia]. Z Gerontol Geriatr (2016) 0.79
Is working later in life good or bad for health? An investigation of multiple health outcomes. J Gerontol B Psychol Sci Soc Sci (2013) 0.79
Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment. J Geriatr Psychiatry Neurol (2015) 0.79
Mechanisms underlying neurocognitive dysfunctions in recurrent major depression. Med Sci Monit (2015) 0.79
Prognosis of mild cognitive impairment in general practice: results of the German AgeCoDe study. Ann Fam Med (2014) 0.79
Lifetime affect and midlife cognitive function: prospective birth cohort study. Br J Psychiatry (2013) 0.79
Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm (Vienna) (2012) 0.79
Prevalence and covariates of elevated depressive symptoms in rural memory clinic patients with mild cognitive impairment or dementia. Dement Geriatr Cogn Dis Extra (2014) 0.78
DASH and Mediterranean-type Dietary Patterns to Maintain Cognitive Health. Curr Nutr Rep (2014) 0.78
Social relationships and risk of incident mild cognitive impairment in U.S. Alzheimer's disease centers. Alzheimer Dis Assoc Disord (2014) 0.78
Isolation Housing Exacerbates Alzheimer's Disease-Like Pathophysiology in Aged APP/PS1 Mice. Int J Neuropsychopharmacol (2015) 0.78
Structural neuroimaging of concomitant depressive symptoms in amnestic mild cognitive impairment: a pilot study. Dement Geriatr Cogn Dis Extra (2012) 0.77
Depressive symptoms in neurodegenerative diseases. World J Clin Cases (2015) 0.77
Treatment-resistant Late-life Depression: Challenges and Perspectives. Curr Neuropharmacol (2015) 0.77
Association of depression and loneliness with specific cognitive performance in non-demented elderly males. Med Sci Monit (2015) 0.77
Meditation as a therapeutic intervention for adults at risk for Alzheimer's disease - potential benefits and underlying mechanisms. Front Psychiatry (2014) 0.77
A score based on screening tests to differentiate mild cognitive impairment from subjective memory complaints. Neurol Int (2013) 0.77
Cognitive Impairment, Depression, and Cooccurrence of Both among the Elderly in Panama: Differential Associations with Multimorbidity and Functional Limitations. Biomed Res Int (2015) 0.76
A Reanalysis of Cognitive-Functional Performance in Older Adults: Investigating the Interaction Between Normal Aging, Mild Cognitive Impairment, Mild Alzheimer's Disease Dementia, and Depression. Front Psychol (2016) 0.76
Late-life depression is not associated with dementia-related pathology. Neuropsychology (2016) 0.76
The role of APOE-ɛ4 and beta amyloid in the differential rate of recovery from ECT: a review. Transl Psychiatry (2015) 0.76
Validity of Addenbrooke's Cognitive Examination to Discriminate between Incipient Dementia and Depression in Elderly Patients of a Private Clinic in Lima, Peru. Dement Geriatr Cogn Dis Extra (2013) 0.75
Serum Levels of ApoA1 and ApoA2 Are Associated with Cognitive Status in Older Men. Biomed Res Int (2015) 0.75
Neuropsychological Profile of "Cognitive Frailty" Subjects in MAPT Study. J Prev Alzheimers Dis (2016) 0.75
Association between Cerebral Amyloid Deposition and Clinical Factors Including Cognitive Function in Geriatric Depression: Pilot Study Using Amyloid Positron Emission Tomography. Clin Psychopharmacol Neurosci (2016) 0.75
Trajectories of Depressive Symptomatology in Rural Memory Clinic Patients between Baseline Diagnosis and 1-Year Follow-Up. Dement Geriatr Cogn Dis Extra (2016) 0.75
Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study. Parkinsons Dis (2016) 0.75
Serum Soluble Adhesion Molecules and Markers of Systemic Inflammation in Elderly Diabetic Patients with Mild Cognitive Impairment and Depressive Symptoms. Biomed Res Int (2015) 0.75
Reconsidering Animal Models of Major Depressive Disorder in the Elderly. Front Aging Neurosci (2016) 0.75
The mediational role of physical activity, social contact and stroke on the association between age, education, employment and dementia in an Asian older adult population. BMC Psychiatry (2017) 0.75
Nonmedical treatment of patients with dementia. Innov Clin Neurosci (2011) 0.75
Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic treatment outcomes for younger versus older patients. J Affect Disord (2017) 0.75
Effect of XingPiJieYu decoction on spatial learning and memory and cAMP-PKA-CREB-BDNF pathway in rat model of depression through chronic unpredictable stress. BMC Complement Altern Med (2017) 0.75
Disrupted global metastability and static and dynamic brain connectivity across individuals in the Alzheimer's disease continuum. Sci Rep (2017) 0.75
Association of Cerebral Amyloidosis, Blood Pressure, and Neuronal Injury with Late-Life Onset Depression. Front Aging Neurosci (2016) 0.75
Depressive Symptoms, Cognition, and Everyday Function Among Community-Residing Older Adults. J Aging Health (2016) 0.75
The interface between depression and dementia: where are we with this important frontier? Am J Geriatr Psychiatry (2010) 0.75
The Comorbid Influence of High Depressive Symptoms and Diabetes on Mortality and Disability in Mexican Americans Aged 75 and Above. Gerontol Geriatr Med (2016) 0.75
Technology-adaptable interventions for treating depression in adults with cognitive impairments: protocol for a systematic review. Syst Rev (2015) 0.75
Organic bases of late-life depression: a critical update. J Neural Transm (Vienna) (2013) 0.75
Dual Tasking for the Differentiation between Depression and Mild Cognitive Impairment. Front Aging Neurosci (2016) 0.75
Design and Implementation of an Intervention Development Study: Retaining Cognition While Avoiding Late-Life Depression (ReCALL). Am J Geriatr Psychiatry (2015) 0.75
Divergent Roles of Vascular Burden and Neurodegeneration in the Cognitive Decline of Geriatric Depression Patients and Mild Cognitive Impairment Patients. Front Aging Neurosci (2017) 0.75
Increased Risk of Osteoporosis in Depressive Patients with Erectile Dysfunction: A Cross-sectional Study from Malaysia. J Pharm Bioallied Sci (2017) 0.75
Greater Cortical Thickness in Elderly Female Yoga Practitioners-A Cross-Sectional Study. Front Aging Neurosci (2017) 0.75
Mild cognitive impairment in Parkinson's disease: a distinct clinical entity? Transl Neurodegener (2017) 0.75
A longitudinal study of cognitive trajectories in Mexican Americans age 75 and older. Int J Geriatr Psychiatry (2016) 0.75
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol (2007) 4.03
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology (2007) 2.32
An association study between epicardial fat thickness and cognitive impairment in the elderly. Am J Physiol Heart Circ Physiol (2014) 2.06
Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease. J Am Geriatr Soc (2008) 2.05
Transthoracic ultrasound in the evaluation of pulmonary fibrosis: our experience. Ultrasound Med Biol (2008) 1.80
The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol (2008) 1.64
Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry (2005) 1.63
Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res (2008) 1.60
Postconditioning is an effective strategy to reduce renal ischaemia/reperfusion injury. Nephrol Dial Transplant (2008) 1.57
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res (2004) 1.55
Dietary intake of unsaturated fatty acids and age-related cognitive decline: a 8.5-year follow-up of the Italian Longitudinal Study on Aging. Neurobiol Aging (2005) 1.46
Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol (2003) 1.45
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease. Intern Emerg Med (2011) 1.42
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
Short-term effects of high-intensity laser therapy versus ultrasound therapy in the treatment of people with subacromial impingement syndrome: a randomized clinical trial. Phys Ther (2009) 1.35
From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol (2012) 1.33
Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a geriatric unit: a prospective study of 1756 patients. Drug Saf (2008) 1.31
Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev (2010) 1.30
Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication. Am J Gastroenterol (2007) 1.28
Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis (2010) 1.23
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies. Immunotherapy (2012) 1.18
The Multidimensional Prognostic Index (MPI), based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J Alzheimers Dis (2009) 1.16
Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer. Epigenetics (2011) 1.12
Diverticular disease in the elderly. Dig Dis (2007) 1.11
Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology (2004) 1.10
Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide. J Biol Chem (2007) 1.08
Fatal systemic venous air embolism during endoscopic retrograde cholangiopancreatography. Adv Anat Pathol (2009) 1.08
Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective? Int J Geriatr Psychiatry (2012) 1.08
Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion. J Med Chem (2005) 1.07
Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimers Dis (2010) 1.06
Dietary fatty acids intake: possible role in cognitive decline and dementia. Exp Gerontol (2005) 1.06
Lifestyle-related factors in predementia and dementia syndromes. Expert Rev Neurother (2008) 1.06
Oxidative stress and aging. J Nephrol (2010) 1.06
Marital and cohabitation status as predictors of mortality: a 10-year follow-up of an Italian elderly cohort. Soc Sci Med (2008) 1.05
Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. Prog Lipid Res (2011) 1.05
The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. J Surg Res (2005) 1.05
Mitochondrial involvement in non-alcoholic steatohepatitis. Mol Aspects Med (2007) 1.05
Oxidation of hepatic carnitine palmitoyl transferase-I (CPT-I) impairs fatty acid beta-oxidation in rats fed a methionine-choline deficient diet. PLoS One (2011) 1.04
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option? Expert Opin Investig Drugs (2011) 1.04
Mutations of the D310 mitochondrial mononucleotide repeat in primary tumors and cytological specimens. Cancer Lett (2003) 1.04
Mitochondrial function in liver disease. Front Biosci (2007) 1.03
Diet and Alzheimer's disease risk factors or prevention: the current evidence. Expert Rev Neurother (2011) 1.03
Circulating biomarkers of cognitive decline and dementia. Clin Chim Acta (2005) 1.03
Disease-modifying approach to the treatment of Alzheimer's disease: from alpha-secretase activators to gamma-secretase inhibitors and modulators. Drugs Aging (2009) 1.02